000 | 02576ngm a2200529 a 4500 | ||
---|---|---|---|
001 | HST5496 | ||
003 | UkLoHST | ||
006 | m c | ||
007 | cr|cna|||a|||| | ||
007 | vz|czazum | ||
008 | 210204s2021 enk|||||||||||s|||v|eng d | ||
028 | 5 | 0 |
_a5496 _bHenry Stewart Talks |
035 | _a(UkLoHST)4505 | ||
040 |
_aUkLoHST _beng _cUkLoHST |
||
100 | 1 |
_aLewis, James H. _4spk |
|
245 | 1 | 0 |
_aDrug-induced liver injury _h[electronic resource] : _brisk factors and drug development in DILI / _cJames H. Lewis. |
246 | 1 |
_iTitle from title frames _aDrug-induced liver injury : where we have been and where we are headed. Part 2 of 3, Risk factors and drug development in DILI |
|
260 |
_aLondon : _bHenry Stewart Talks, _c2021. |
||
300 |
_a1 online resource (1 streaming video file (26 min.) : _bcolor, sound). |
||
490 | 1 |
_aGastroenterology and hepatology : pathophysiology, presentation, diagnosis and management, _x2056-452X |
|
490 | 1 |
_aPeriodic reports : advances in clinical interventions and research platforms, _x2056-452X |
|
500 | _aAnimated audio-visual presentation with synchronized narration. | ||
500 | _aTitle from publisher's web site. | ||
500 | _aUpdated version of a talk first published in 2011. | ||
505 | 0 | _aContents: DILI risk factors -- Racial differences in DILI -- Statin use -- Drug metabolism -- Genetic risk factors for DILI -- Outcomes for DILI -- Regulatory science -- Hy's law and eDISH. | |
506 | _aAccess restricted to subscribers. | ||
538 | _aMode of access: World Wide Web. | ||
650 | 0 |
_aDrugs _xSide effects. |
|
650 | 0 | _aHepatotoxicology. | |
650 | 0 |
_aLiver _xDiseases _xEtiology. |
|
650 | 0 |
_aLiver _xEffect of drugs on. |
|
650 | 2 |
_aChemical and Drug Induced Liver Injury _xetiology. |
|
650 | 2 |
_aChemical and Drug Induced Liver Injury _xgenetics. |
|
650 | 2 | _aDrug Approval. | |
650 | 2 | _aDrug Development. | |
650 | 2 | _aDrug-Related Side Effects and Adverse Reactions. | |
650 | 2 | _aHydroxymethylglutaryl-CoA Reductase Inhibitors. | |
650 | 2 |
_aLiver _xdrug effects. |
|
650 | 2 | _aMetabolic Clearance Rate. | |
650 | 2 | _aPharmacogenetics. | |
650 | 2 | _aRisk Factors. | |
830 | 0 |
_aHenry Stewart talks. _pBiomedical & life sciences collection. _pGastroenterology and hepatology. |
|
830 | 0 |
_aHenry Stewart talks. _pBiomedical & life sciences collection. _pPeriodic reports. |
|
856 | 4 | 0 | _uhttps://hstalks.com/bs/4505/ |
856 | 4 | 2 |
_uhttps://hstalks.com/bs/p/1048/ _3Series (Periodic reports) |
856 | 4 | 2 |
_uhttps://hstalks.com/bs/p/532/ _3Series (Gastroenterology and hepatology) |
999 |
_c75853 _d75853 |